This event has taken place.
Thank you for your interest in The Prevention of Preterm Birth: Cervical Ultrasound and Vaginal Progesterone. Three CME-certified enduring activities are being developed based on the content presented at this live meeting:
- Medscape online Test and Teach program (expected launch: August 2011)
- Medscape online Spotlight program (expected launch: September 2011)
- Supplement to the American Journal of Obstetrics and Gynecology (expected distribution: December 2011)
If you would like to receive notification when each program is available, please send an e-mail to email@example.com
We appreciate your interest in these CME-certified programs.
||Grand Hyatt Washington
||Monday, May 02, 2011 6:00 PM
||To register scroll down.
Preterm birth (PTB) – birth at <37 completed weeks of gestation – is a major public health problem in the US. Data from 2008 show that PTB occurs in approximately 13% of pregnancies, accounting for more than 500,000 births. Preterm neonates are at greater risk for morbidity and mortality than infants born at term. A variety of health and developmental complications may arise, including acute respiratory distress syndrome, central nervous system deficits, vision impairments, gastrointestinal problems, and long-term motor and cognitive disabilities. PTB has considerable emotional and economic impacts on families and causes a significant burden to the health care system. According to 2005 estimates, the annual cost of PTB in the US was at least $26.2 billion – or $51,600 per infant born preterm. The largest portion of these costs, $16.9 billion, was for medical care services – more than 85% of which occurred in infancy.
Although significant improvements have been made in treating preterm infants and improving survival, little success has been attained in fully understanding PTB and reducing its incidence. Recently, methods have been identified that may improve outcomes. Measurement of cervical length by transvaginal ultrasound at mid-gestation may be the single best predictor of subsequent PTB. Once a short cervix has been identified, interventions such as cervical cerclage and use of prophylactic progesterone therapy may stop progression to preterm birth, resulting in improved outcomes.
ROBERTO ROMERO, MD (Program Chair)
Chief, Perinatology Research Branch
Program Director for Perinatal Research and Obstetrics
SONIA S. HASSAN, MD
Director, Center for Advanced Obstetrical Care and Research
Perinatology Research Branch/NICHD/NIH/DHHS
Director, PRB/DMC/WSU Maternal- Fetal Medicine Fellowship Program
Division of Maternal-Fetal Medicine
Department of Obstetrics and Gynecology
Wayne State University
Hutzel Women’s Hospital
R. ANN WORD, MD
Professor of Obstetrics and Gynecology
University of Texas
Southwestern Medical School
This activity is intended for gynecologists, obstetricians, pharmacists, physician assistants, and nurses.
This program is designed to address the following IOM competencies: provide patient-centered care and employ evidence-based practice.
At the conclusion of this activity, participants should be able to:
- Discuss and explain the clinical and economic impact of PTB
- Recognize patients at risk for PTB and initiate screening strategies
- Explain the data linking the impact of the short cervix with PTB
- Employ routine transvaginal ultrasonography to measure cervical length in all pregnant patients
- Assess the risks/benefits of current and emerging interventions
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Wayne State University School of Medicine and Rockpointe Corporation. The Wayne State University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
The Detroit Medical Center Department of Pharmacy Services is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Global Education Group is an approved provider of continuing nursing education by the Colorado Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.
The Wayne State University School of Medicine designates this educational activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
For questions regarding CME credit, the post-test, or evaluation, please email: firstname.lastname@example.org.
Full attendance at this program and completion of the program evaluation and learning assessment will provide 1.5 contact hours (0.15 CEUs) of pharmacy continuing education. Universal Activity Number (UAN): 510-9999-11-013-L01-P.
This activity has been designated as a knowledge-based activity.
For questions regarding CE credit, the post-test, or evaluation, please email: JMacDona@dmc.org.
This educational activity for 1.5 contact hours is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
For information about the nursing accreditation of this program, please contact Global at email@example.com or 303-395-1782.
It is our policy to ensure balance, independence, objectivity, and scientific rigor in all of our educational programs. Faculty, course directors, program planners/managers and their spouses/life partners have disclosed relevant financial relationships with commercial companies, and Wayne State University, Detroit Medical Center, and Global Education Group have processes in place to resolve any conflict of interest. Complete disclosures will be provided to program participants at the beginning of the activity and will be printed in the handouts.
METHOD OF PARTICIPATION
To complete this activity and receive credit, the participant must attend the program, and complete the evaluation form. A CME certificate will be mailed within 6-8 weeks.
There are no fees associated with this program.
Event staff will be glad to assist you with any special needs (e.g. physical, dietary, etc.). Please email firstname.lastname@example.org at least 5 days prior to the program.
Jointly Sponsored By
This event is neither sponsored nor endorsed by the American College of Obstetricians and Gynecologists
|Nursing credit provided by:
Supported by an unrestricted educational grant from Watson Pharmaceuticals, Inc.
By clicking the Registration Button below you are agreeing that you have read and understood the CME Statements above.
Pre-registration is not required for attendance. Seating is limited and will be provided on a first-come, first serve basis.